LD Micro Main Event

December 6-8, 2016

Luxe Hotel Sunset Boulevard (Los Angeles)

Taking place in Bel Air, California, LD Micro's annual Main Event conference is a collection of 240 companies from all around the globe, representing all industries. It is the only conference where the most influential names of the buy-side and sell-side gather to collaborate, research and invest.

  Track 1 Track 2 Track 3 Track 4 Track 5
7:30am S&W Seed Company (SANW) GWG Holding, Inc. (GWGH) ICTV Brands (ICTV) Fision Corp. (FSSN) Biomerica, Inc. (BMRA)
8:00 iCAD, Inc. (ICAD) Asterias Biotherapeutics (AST) Biocept, Inc. (BIOC) NovaBay Pharmaceuticals (NBY) Patriot One Technologies, Inc. (PTOTF)
8:30 Miramar Labs (MRLB) Check-Cap (CHEK) Bion Environmental Technologies (BNET) Gemphire Therapeutics, Inc. (GEMP) CAS Medical Systems (CASM)
9:00 Newtek Business Services (NEWT) Lakeland Industries (LAKE) Provision Holding (PVHO) Caladrius Biosciences, Inc. (CLBS) Charles & Colvard (CTHR)
9:30 Nephros, Inc. (NEPH) Zoned Properties, Inc. (ZDPY) Cemtrex Inc. (CETX) Valeritas Holdings (VLRX) Park City Group, Inc. (PCYG)
10:00 Finjan Holdings, Inc. (FNJN) Coffee Holding Company, Inc. (JVA) MagneGas Corp. (MNGA) Bridgeline Digital, Inc. (BLIN) Moleculin Biotech, Inc. (MBRX)
10:30 22nd Century Group, Inc. (XXII) iPass, Inc. (IPAS) BioLineRx Ltd. (BLRX) Tonix Pharmaceuticals Holding Corp. (TNXP) Heat Biologics (HTBX)
11:00 NAPCO Security Technologies, Inc. (NSSC) Xplore Technologies Corp. (XPLR) First Choice Healthcare Solutions, Inc. (FCHS) Ritter Pharmaceuticals, Inc. (RTTR) MassRoots, Inc. (MSRT)
11:30 Simulations Plus (SLP) BioSig Technologies, Inc. (BSGM) Akoustis Technologies, Inc. (AKTS) VBI Vaccines, Inc. (VBIV) Luna Innovations, Inc. (LUNA)
12:00pm WidePoint Corp. (WYY) Salem Media Group, Inc. (SALM) Delcath Systems, Inc. (DCTH) TheStreet, Inc. (TST)
12:30 GSI Technology, Inc. (GSIT) One Horizon Group (OHGI) Atossa Genetics, Inc. (ATOS) Optex Systems Holdings (OPXS)
1:00 Mobivity Holdings Corp. (MFON) Propanc Health Group Corp. (PPCH) Exactus, Inc. (EXDI) Function(x) Inc. (FNCX)
1:30 Tio Networks (TNCGF) Arch Therapeutics, Inc. (ARTH) Kindred Biosciences, Inc. (KIN) Inventergy Global, Inc. (INVT) Full House Resorts, Inc. (FLL)
2:00 RCI Hospitality Holdings, Inc. (RICK) Chanticleer Holdings (HOTR) MabVax Therapeutics Holdings (MBVX) CytoDyn, Inc. (CYDY) Youngevity International, Inc. (YGYI)
2:30 Second Sight Medical Products (EYES) Terra Tech Corp. (TRTC) RMG Networks Holding Corp. (RMGN) Relmada Therapeutics (RLMD) Inuvo, Inc. (INUV)
3:00 SharpSpring, Inc. (SHSP) GrowGeneration Corp. (GRWG) Cesca Therapeutics (KOOL) First Harvest Corp. (HVST) TrackX Holdings (TKXHF)
3:30 Sevcon, Inc. (SEV) Medovex Corp. (MDVX) Stellar Biotechnologies, Inc. (SBOT) Reign Sapphire Corp. (RGNP)
4:00 Sunworks, Inc. (SUNW) Medite Cancer Diagnostics (MDIT) OncoSec Medical Inc. (ONCS)
4:30 Cytosorbents Corp. (CTSO) Pioneering Technology Corp. (PTEFF) Genius Brands International, Inc. (GNUS) Flux Power Holdings, Inc. (FLUX) Xenetic Biosciences, Inc. (XBIO)
5:00 TESSCO Technologies, Inc. (TESS) NTN Buzztime, Inc. (NTN) Reed's, Inc. (REED)

7:30 am

S&W Seed Company (SANW)

S&W Seed Company (NASDAQ: SANW) is a global agricultural company aiming to be the world's preferred proprietary seed company by supplying a range of forage and specialty crop products to support the growing global demand for animal proteins and healthier consumer diets. The company is the global leader in alfalfa seed, with capabilities that span the world's alfalfa seed production regions. S&W has operations in the United States, Australia, and Canada, and sells its seed products in more than 30 countries around the globe. The company also provides proprietary hybrid sorghum and sunflower seed germplasm, and is utilizing its research and breeding expertise to develop and produce stevia, the all-natural, zero calorie sweetener for the food and beverage industry. For more information, visit the company's website at www.swseedco.com.

GWG Holding (GWGH)

GWG Holding (NASDAQ: GWGH) is a specialty finance company that purchases life insurance policies in the secondary market in the United States. It purchases or finances life insurance assets from consumers at a discount to the face value of the policy benefit. The company purchases policies in the secondary market through financial advisors and life insurance agents, as well as through its appointed agent program. It also purchases life insurance assets directly from policy owners who purchased their life insurance in the primary market; and is involved in the merchant cash advance business. For more information, visit the company's website at www.gwglife.com.

ICTV Brands (ICTV)

ICTV Brands (OTC: ICTV) is a direct response marketing and international branding company that sells various health, wellness and beauty products. The company develops, markets and sells its products through a multi-channel distribution strategy, including direct response television, digital marketing campaigns, live home shopping, traditional retail and e-commerce market places, and international third-party distributor network. Its products include DermaWand, a skin care device that reduces the appearance of fine lines and wrinkles; DermaVital, a skin care line; and CoralActives, a line of acne treatment and skin cleansing products. For more information, visit the company's website at www.ictvbrands.com.

Fision (FSSN)

Fision (OTC: FSSN) is a cloud-based digital asset management and marketing automation company. The company's advanced, proprietary technology specializes in managing a customer's brand and marketing content to enable marketing and sales people to quickly and easily create compelling, personalized, on-brand communications, which increases revenue and profits. With more than 65,000 users in 21 countries, FISION services enterprise clients in the health care, hospitality, financial/insurance, software and technology industries. For more information, visit the company's website at www.fisiononline.com.

Biomerica (BMRA)

Biomerica (NASDAQ: BMRA) is a global biomedical company that develops, manufactures and markets advanced diagnostic products used at the point-of-care (in home and in physicians' offices) and in hospital/clinical laboratories for the early detection of medical conditions and diseases. The company's products are designed to enhance health and well-being, while reducing total healthcare costs. Biomerica primarily focuses on products for gastrointestinal disease, diabetes, and esoteric testing. For more information, visit the company's website at www.biomerica.com.

8:00 am


iCAD (NASDAQ: ICAD) is a pharmaceutical company that delivers innovative cancer detection and radiation therapy solutions and services that enable clinicians to find and treat cancers earlier and faster while improving patient outcomes. The company offers a comprehensive range of upgradeable computer-aided detection (CAD) and workflow solutions to support rapid and accurate detection of breast, prostate and colorectal cancers. iCAD's Xoft® Axxent® Electronic Brachytherapy (eBx®) System® is a painless, non-invasive technology that delivers high dose rate, low energy radiation, which targets cancer while minimizing exposure to surrounding healthy tissue. For more information, visit the company's website at www.icadmed.com.

Asterias Biotherapeutics (AST)

Asterias Biotherapeutics (NYSE: AST) is a clinical-stage biotechnology company focusing on developing and commercializing novel therapies in the fields of cell therapy and regenerative medicine specifically for the areas of neurology and oncology. Asterias is developing AST-VAC1, an autologous product candidate that completed phase II clinical trials for the treatment of acute myelogenous leukemia; and AST-VAC2, an allogeneic, or non-patient specific, cancer vaccine candidate designed to stimulate patient immune responses to telomerase that is in pre-clinical stage. For more information, visit the company's website at www.asteriasbiotherapeutics.com.

Biocept (BIOC)

Biocept (NASDAQ: BIOC) is a cancer diagnostics company that develops and commercializes proprietary circulating tumor cell (CTC) and circulating tumor DNA assays utilizing a standard blood sample. The company's cancer assays provide information to oncologists and other physicians that enable them to select personalized treatment for their patients based on detailed data on the characteristics of tumors. It offers assays for solid tumor indications, such as breast cancer, lung cancer, gastric cancer, colorectal cancer, prostate cancer and melanoma. For more information, visit the company's website at www.biocept.com.

NovaBay Pharmaceuticals (NBY)

NovaBay Pharmaceuticals (NYSE: NBY) is an innovative biopharmaceutical company that develops and commercializes non-antibiotic anti-infective products for the eye care market. Its commercial products include the Neutrox family of products; Avenova for the eye care market; NovaClear intelli-Case, a device for soft and rigid gas permeable contact lenses; Neutrophase for wound care; CelleRx for the dermatology market; and Aganocide compounds patented synthetic molecules with a range of spectrum of activity against bacteria, viruses and fungi to mimic the mechanism of action against infections with a low likelihood of developing bacterial and viral resistance. For more information, visit the company's website at www.novabay.com.

Patriot One Technologies (PTOTF)

Patriot One Technologies (OTC:PTOTF) is a tech company currently advancing five years of academic research and successful testing into a commercial first-of-its-kind Cognitive Microwave Radar concealed weapons detection system. The company's NForce CMR1000 aims to deter, detect and defend against active shooter threats before they occur. NForce CMR1000 can be cost-effectively installed in hallways and doorways to covertly identify weapons and to alert security of active threats before entry. For more information, visit the company's website at www.patriot1tech.com.

8:30 am

Miramar Labs (MRLB)

Miramar Labs (OTC: MRLB) develops, manufactures and distributes medical devices to treat dermatologic medical conditions. The company's portfolio includes miraWave technology, a platform that leverages microwave energy to treat dermatologic conditions, as well as for treatments in other medical areas, such as oncology, cardiology and urology; miraDry, a procedure that uses microwave energy to provide a non-invasive solution for the treatment of axillary hyperhidrosis; and miraSmooth, a solution for plastic surgery and dermatology practices. For more information, visit the company's website at www.miramarlabs.com.

Check-Cap (CHEK)

Check-Cap (NASDAQ: CHEK) is a clinical-stage medical diagnostics company that engages in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the screening for precancerous polyps and cancer. Its products include an ingestible capsule with a colon imaging system for colorectal cancer and pre-cancerous polyps that utilizes X-ray-based technology to generate 3-dimensional imagery of the colon without cleansing or other aggressive bowel preparation. For more information, visit the company's website at www.check-cap.com.

Bion Environmental Technologies (BNET)

Bion Environmental Technologies (OTC: BNET) develops patented and proprietary technology providing environmental solutions to a source of pollution in agriculture and confined animal feeding operations (CAFOs) in the United States and internationally. The company's technology produces the reductions of nutrient releases to water and air, including ammonia from livestock waste streams. Bion focuses on the installation of its systems to retrofit and environmentally remediate existing CAFOs; develop waste treatment facilities; and licensing and/or joint venturing of its technology and applications. For more information, visit the company's website at www.biontech.com.

Gemphire Therapeutics (GEMP)

Gemphire Therapeutics (NASDAQ: GEMP) is a clinical-stage biopharmaceutical company focusing on developing and commercializing therapies for the treatment of dyslipidemia cardiovascular disease. The company's leading product candidate is Gemcabene (CI-1027), an oral therapy for patients who are unable to achieve normal levels of LDL-C or triglycerides with currently approved therapies. For more information, visit the company's website at www.gemphire.com.

CAS Medical Systems (CASM)

CAS Medical Systems (NASDAQ: CASM) is a medical technology company that develops, manufactures and markets non-invasive patient monitoring products. The vompany's FORE-SIGHT® Cerebral Oximeters provide a highly accurate, non-invasive measurement of tissue oxygenation in the brain. Direct monitoring of tissue oxygenation can provide a superior and powerful tool to alert clinicians to otherwise unrecognized and dangerously low levels of oxygen in the brain and empower them to improve patient care. CAS Medical also provides proprietary non-invasive blood pressure monitoring solutions for OEM use and neonatal intensive care supplies. For more information, visit the company's website at www.corporate.casmed.com.

9:00 am

Newtek Business Services (NEWT)

Newtek Business Services (NASDAQ: NEWT) is a business development company specializing in providing financial and business services to the small-and medium-sized business market in the United States. The company also seeks to invest in early stage businesses and makes both debt and equity investments. Under debt investments, it focuses on first lien loans, which have terms of one to 25 years; second lien loans, which have terms of five to 25 years; and unsecured loans, which are provided to meet short-term funding needs and are repaid within six to 12 months. It operates through electronic payment processing, managed technology solutions, small business finance, and Capcos segments. For more information, visit the company's website at www.newtekone.com.

Lakeland Industries (LAKE)

Lakeland Industries (NASDAQ: LAKE) manufactures and sells a range of safety garments and accessories for the industrial and public protective clothing. The company offers limited use/disposable protective clothing; high-end chemical protective suits to provide protection from highly concentrated and hazardous chemical and biological toxins; and firefighting and heat protective apparel, which is used for the maintenance of high temperature equipment, and for military and airport crash and rescue teams. For more information, visit the company's website at www.lakeland.com.

Provision Holding (PVHO)

Provision Holding (OTC: PVHO) provides three-dimensional (3D) holographic display technologies, software and integrated solutions for both commercial and consumer-focused applications. The company's initial line of display systems is ideally suited for indoor and outdoor point-of-sale (POS), merchandising and point of sale-related advertising venues, positioning the company as a market leader in true 3D consumer advertising display products being implemented by leading consumer-focused Fortune 1000 companies. For more information, visit the company's website at www.provision.tv.

Caladrius Biosciences (CLBS)

Caladrius Biosciences (NASDAQ: CLBS) is advancing a proprietary platform technology for immunomodulation by pioneering the use of T regulatory cells as an innovative therapy for recent onset type 1 diabetes. The company's product candidate, CLBS03, is the subject of an ongoing phase 2 clinical trial in collaboration with Sanford Research, and has been granted Orphan Drug and Fast Track designation by the FDA and Advanced Therapeutic Medicinal Product classification by the European Medicines Agency. The company's PCT subsidiary is a development and manufacturing partner to the cell therapy industry. For more information, visit the company's website at www.caladrius.com.

Charles & Colvard (CTHR)

Charles & Colvard (NASDAQ: CTHR) is the original creator and leading source of Forever Classic™, Forever Brilliant® and Forever One™ moissanite gemstones for fine jewelry. Moissanite is unique, available in three color grades (colorless, near-colorless and faint color) and produced from silicon carbide (SiC) crystals. Charles & Colvard Created Moissanite® is sold with a Certificate of Authenticity and Limited Lifetime Warranty to wholesale distributors, manufacturers, retailers, TV shopping networks and designers as loose stones or set in a wide variety of quality metal setting options. Charles & Colvard, Ltd. also sells direct to consumers through its wholly owned operating subsidiary, charlesandcolvard.com, LLC, and through third-party marketplaces. For more information, visit the company's website at www.charlesandcolvard.com.

9:30 am

Nephros (NEPH)

Nephros (OTC: NEPH) is a commercial-stage medical device and commercial product company that develops and sells liquid purification filters and hemodiafiltration systems. The company's ultrafilters are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate, and in hospitals for the prevention of infection from water borne pathogens such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and other healthcare facilities. For more information, visit the company's website at www.nephros.com.

Zoned Properties (ZDPY)

Zoned Properties (OTC: ZDPY) is a strategic real estate company whose primary mission is to identify, develop and lease sophisticated safe and sustainable properties in emerging industries. Initially, the company has focused the majority of its resources on the development of properties and projects within the licensed medical marijuana industry. The core of ZDPY's business involves identifying and acquiring properties that exist within highly regulated zoning regions and could be candidates for re-zoning or long-term development deals with the local municipality. For more information, visit the company's website at www.zonedproperties.com.

Cemtrex (CETX)

Cemtrex (NASDAQ: CETX) is a diversified industrial and manufacturing company that provides a wide array of solutions to meet today's technology challenges. The company provides advanced custom engineered electronics and emission monitors, as well as instruments for industrial processes. It also provides environmental control and air filtration systems for various industries and utilities. For more information, visit the company's website at www.cemtrex.com.

Valeritas Holdings (VLRX)

Valeritas Holdings (OTC: VLRX) is a commercial-stage medical technology company focused on developing innovative technologies to improve the health and quality of life of people with Type 2 diabetes. The company's flagship product, the V-Go® Disposable Insulin Delivery device, is a simple, wearable, basal-bolus, insulin delivery solution for patients with Type 2 diabetes that enables the administration of a continuous preset basal rate infusion of insulin over 24 hours. For more information, visit the company's website at www.valeritas.com.

Park City Group (PCYG)

Park City Group (NASDAQ: PCYG) is a software-as-a-service provider that designs, develops, markets and supports proprietary software products for the consumer goods supply chain. The company offers its products for businesses having multiple locations to assist in the management of business operations on a daily basis and communicate results of operations in a timely manner. Park City Group provides advanced commerce and supply-chain solutions, such as Scan Based Trading, ScoreTracker, Enterprise Supply Chain Planning, Fresh Market Manager, and ActionManager, which are designed to enable the retailer and supplier to manage inventory, product mix and labor. For more information, visit the company's website at www.parkcitygroup.com.

10:00 am

Finjan Holdings (FNJN)

Finjan Holdings (NASDAQ: FNJN) is a cybersecurity company providing intellectual property licensing and enforcement services. The company owns a portfolio of patents related to software and hardware technologies that proactively detect malicious code and thereby protects end-users from identity and data theft, spyware, malware, phishing, trojans and other Web and network threats. Its patented technologies are used in specific technology areas, including endpoint/cloud software, web gateway/Internet infrastructure, and networking equipment markets. For more information, visit the company's website at www.finjan.com.

Coffee Holding Company (JVA)

Coffee Holding Company (NASDAQ: JVA) manufactures, roasts, packages, markets and distributes roasted and blended coffees in the United States, Canada, Australia, England and China. The company offers wholesale green coffee products, which include unroasted raw beans of approximately 90 varieties that are sold to large, medium, and small roasters, as well as to coffee shop operators. It also roasts, blends, packages and sells coffee under private labels. For more information, visit the company's website at www.coffeeholding.com.

MagneGas (MNGA)

MagneGas (NASDAQ: MNGA) owns a patented process that converts various renewables and liquid wastes into MagneGas fuels for use as an alternative to natural gas or for metal cutting. The company's testing has shown that its metal cutting fuel "MagneGas2®" is faster, cleaner and more productive than other alternatives on the market. The company currently sells MagneGas2® into the metal working market as a replacement to acetylene. MagneGas also sells equipment for the sterilization of bio-contaminated liquid waste for various industrial and agricultural markets, and is developing a variety of ancillary uses for MagneGas® fuels utilizing its high flame temperature for co-combustion of hydrocarbon fuels and other advanced applications. For more information, visit the company's website at www.magnegas.com.

Bridgeline Digital (BLIN)

Bridgeline Digital (NASDAQ: BLIN) is a digital company that helps customers maximize the performance of their full digital experience – from websites and intranets to online stores and campaigns. The company's iAPPS platform deeply integrates web content management, eCommerce, eMarketing, social media management, and Web Analytics to help marketers deliver digital experiences that attract, engage and convert their customers across all channels. For more information, visit the company's website at www.bridgelinedigital.com.

Moleculin Biotech (MBRX)

Moleculin Biotech (NASDAQ: MBRX) is a preclinical and clinical-stage pharmaceutical company focused on the development of anti-cancer drug candidates, some of which are based on discoveries made at M.D. Anderson Cancer Center. The company's lead product candidate is Annamycin for the treatment of relapsed or refractory acute myeloid leukemia (AML). Moleculin Biotech also has two pre-clinical small molecule portfolios, one of which is focused on the modulation of hard-to-target tumor cell signaling mechanisms and the recruitment of the patient's own immune system. The other portfolio targets the metabolism of tumors. For more information, visit the company's website at www.moleculin.com.

10:30 am

22nd Century Group (XXII)

22nd Century Group (NYSE: XXII) is a plant biotech company providing technology that allows for the level of nicotine and other nicotinic alkaloids in tobacco plants to be decreased or increased through genetic engineering and plant breeding. The company develops smoking cessation products and modified risk tobacco products for smokers who are unable or unwilling to quit smoking and who may be interested in cigarettes, which reduce exposure to nicotine or to certain tobacco smoke toxins and/or pose a lower health risk than conventional cigarettes. For more information, visit the company's website at www.xxiicentury.com.

iPass (IPAS)

iPass (NASDAQ: IPAS) provides global mobile connectivity, offering simple, secure, always-on Wi-Fi access on any mobile device. Built on a software-as-a-service (SaaS) platform, the iPass cloud-based service keeps its customers connected by providing unlimited Wi-Fi connectivity on unlimited devices. iPass is the world's largest Wi-Fi network, with more than 57 million hotspots in more than 120 countries, at airports, hotels, train stations, convention centers, outdoor venues, inflight, and more. Using patented technology, the iPass SmartConnect™ platform automatically connects customers to the best hotspot for their needs. For more information, visit the company's website at www.ipass.com.

BioLineRx (BLRX)

BioLineRx (NASDAQ: BLRX) a clinical-stage biopharmaceutical development company that engages in identifying, in-licensing and developing therapeutic candidates that address unmet medical needs. Its development pipeline consists of three primary clinical-stage therapeutic candidates: BL-8040, a novel peptide for the treatment of multiple cancer and hematological indications; BL-7010, a novel co-polymer for the treatment of celiac disease and gluten sensitivity; and BL-5010, a customized, proprietary, pen-like applicator containing a novel, acidic, aqueous solution as a medical device for the non-surgical removal of benign skin lesions. For more information, visit the company's website at www.biolinerx.com.

Tonix Pharmaceuticals Holding (TNXP)

Tonix Pharmaceuticals Holding (NASDAQ: TNXP) is a clinical-stage pharmaceutical company that develops medicines for common disorders of the central nervous system. The company's lead program focuses on post-traumatic stress disorder (PTSD) that is characterized by chronic disability, inadequate treatment options, high utilization of healthcare services, and economic burden. Its lead product candidate includes TNX-102 SL, a cyclobenzaprine HCl sublingual tablet; a phase III clinical stage for the treatment of PTSD; and phase II clinical stage for the treatment of military-related PTSD. For more information, visit the company's website at www.tonixpharma.com.

Heat Biologics (HTBX)

Heat Biologics (NASDAQ: HTBX) is an immuno-oncology company developing novel therapies designed to activate a patient's immune system against cancer utilizing an engineered form of gp96, a protein that activates the immune system when cells die. Heat's highly specific T cell-stimulating therapeutic vaccine platform technologies, ImPACT and ComPACT, form the basis of its product candidates. Currently, Heat is conducting a phase 2 trial with its HS-410 in patients with non-muscle invasive bladder cancer (NMIBC) and a phase 1b trial with its HS-110 in combination with an anti-PD-1 checkpoint inhibitor to treat patients with non-small cell lung cancer (NSCLC). For more information, visit the company's website at www.heatbio.com.

11:00 am

NAPCO Security Technologies (NSSC)

NAPCO Security Technologies (NASDAQ: NSSC) manufactures and sells security products and software worldwide. It offers access control systems, door security products, intrusion and fire alarm systems, and video surveillance systems for commercial, residential, institutional, industrial and governmental applications. The company's access control systems include various types of identification readers, control panels, PC-based computers, and electronically activated door-locking devices; as well as door locking devices such as microprocessor-based electronic door locks with push button, card readers and bio-metric operation, door alarms, mechanical door locks, and simple dead bolt locks. For more information, visit the company's website at www.napcosecurity.com.

Xplore Technologies (XPLR)

Xplore Technologies (NASDAQ: XPLR) develops, integrates and markets rugged mobile personal computer systems (PCs) in the United States, Canada and internationally. The company's products enable the extension of traditional computing systems to a range of field personnel, including energy pipeline inspectors, public safety personnel, warehouse workers, and pharmaceutical scientists. It offers a line of iX104 tablet PCs that are designed to operate in various work environments, such as extreme temperatures, constant vibrations, rain and blowing dirt and dusty conditions. For more information, visit the company's website at www.xploretech.com.

First Choice Healthcare Solutions (FCHS)

First Choice Healthcare Solutions (OTC: FCHS) is engaged in the provision of healthcare services in the United States. The company's network of non-physician-owned medical centers offer musculoskeletal and rehabilitative care services specializing in orthopedics, spine surgery, neurology, interventional pain management, and ambulatory surgical care. It also provides ancillary and diagnostic services comprising magnetic resonance imaging, X-ray, durable medical equipment, and rehabilitative care, including physical therapy and occupational therapy. For more information, visit the company's website at www.myfchs.com.

Ritter Pharmaceuticals (RTTR)

Ritter Pharmaceuticals (NASDAQ: RTTR) is a pharmaceutical company that develops novel therapeutic products that modulate the human gut microbiome to treat gastrointestinal diseases. Its lead product candidate is RP-G28, a novel microbiome modulator, which is under development for the reduction of symptoms associated with lactose intolerance. The company's RP-G28 is designed to stimulate the growth of lactose-metabolizing bacteria in the colon, thereby adapting the gut microbiome to assist in digesting the lactose that reaches the large intestine. Its RP-G28 has been studied in a phase 2a clinical trial. For more information, visit the company's website at www.ritterpharmaceuticals.com.

MassRoots (MSRT)

MassRoots (OTC: MSRT) operates a technology platform for the cannabis community in the United States. The company's mobile network enables users to share cannabis content to connect with the legalization movement. Its network is accessible as a free mobile application through the iOS App Store and the Google Play marketplace. The company also operates MassRoots.com/shop, an e-commerce platform that allows visitors to order MassRoots T-shirts, jars, and stickers; and MassRoots for Business. For more information, visit the company's website at www.massroots.com.

11:30 am

Simulations Plus (SLP)

Simulations Plus (NASDAQ: SLP) develops and sells drug discovery and development software for mechanistic modeling and simulation. The company offers GastroPlus, which simulates the absorption, pharmacokinetics (PK), and pharmacodynamics of drugs administered to humans and animals; DDDPlus that simulates in vitro laboratory experiments, which measure the rate of dissolution of the drug and additives in a dosage form; and MembranePlus, which simulates laboratory experiments. It also provides PKPlus, a standalone program that provides the functionality needed by pharmaceutical industry scientists to perform the analysis and generate the outputs needed to satisfy regulatory agency requirements for NCA and compartmental PK modelling. For more information, visit the company's website at www.simulations-plus.com.

BioSig Technologies (BSGM)

BioSig Technologies (OTC: BSGM) is a development-stage medical device company that engages in developing a technology platform to minimize noise and artifacts from cardiac recordings during electrophysiology studies and ablation. Its products under development include PURE (Precise Uninterrupted Real-time evaluation of Electrograms) EP system, a surface electrocardiogram and intracardiac multichannel recording and analysis system that acquires, processes, and displays electrocardiogram and electrograms required during electrophysiology studies and ablation procedures. For more information, visit the company's website at www.biosigtech.com.

Akoustis Technologies (AKTS)

Akoustis Technologies (OTC: AKTS) is a tech company that operates in the telecommunications and fiber optics sector. The company designs and manufactures various radio frequency (RF) filters enabling the RF front-end of mobile wireless devices such as smartphones and tablets. It focuses on manufacturing and commercializing its patent-pending Bulk ONE acoustic wave technology to address the frequency-selectivity requirements in mobile smartphones, enhancing the efficiency and signal quality of mobile wireless devices and enabling The Internet of Things. For more information, visit the company's website at www.akoustis.com.

VBI Vaccines (VBIV)

VBI Vaccines (NASDAQ: VBIV) is a commercial-stage biopharmaceutical company developing a next generation of vaccines to address unmet needs in infectious disease and immuno-oncology. VBI's first marketed product is Sci-B-Vac™, a hepatitis B ("HBV") vaccine, which is approved for use in Israel and 14 other countries. The company's eVLP Platform technology allows for the development of enveloped ("e") virus-like particle ("VLP") vaccines that closely mimic the target virus to elicit a potent immune response. VBI is advancing a pipeline of eVLP vaccines, with lead programs in cytomegalovirus ("CMV") and glioblastoma multiforme ("GBM"). VBI is also advancing its LPV™ Thermostability Platform, a proprietary formulation and process that allows vaccines and biologics to preserve stability, potency, and safety. For more information, visit the company's website at www.vbivaccines.com.

Luna Innovations (LUNA)

Luna Innovations (NASDAQ: LUNA) is focused on optical technology, providing unique capabilities in high-speed optoelectronics and high-performance fiber optic test products for the telecommunications industry and distributed fiber optic sensing for the aerospace and automotive industries. The company is organized into two business segments which work closely together to turn ideas into products: a technology development segment and a products and licensing segment. Luna's business model is designed to accelerate the process of bringing new and innovative technologies to market. For more information, visit the company's website at www.lunainc.com.

12:00 pm

WidePoint Corp. (WYY)

WidePoint's (NYSE: WYY) expense management solutions offer a range of dash boards and reports to evaluate communications carrier compliance against a contract, and manage communication assets and expenses. The company also provides identity management and identity assurance services to protect and defend information and information systems; and Certificate-on-Device solution, a robust cloud-based service that offers secure digital certificates to mobile devices. It also offers authenticated order management portal to place, track and manage devices and services requests, as well as other services to enable deployment and management of communication assets across an enterprise; services designed to test, monitor, configure, and manage mobile applications for business and personal use. For more information, visit the company's website at www.widepoint.com.

Salem Media Group (SALM)

Salem Media Group (NASDAQ: SALM) is a multi-media company that operates in three segments: Broadcast, Digital Media, and Publishing. The company owns and operates radio networks, which produce and distribute talk, news and music programming to radio stations in the United States, as well as sells commercial airtime to national advertisers and independent radio station affiliates. It also provides Christian and conservative-themed content, audio and video streaming, and other resources digitally through Christian content websites. For more information, visit the company's website at www.salemmedia.com.

Delcath Systems (DCTH)

Delcath Systems (NASDAQ: DCTH) is a specialty pharmaceutical and medical device company focusing on cancers of the liver. The company is developing its proprietary product-Melphalan Hydrochloride for injection for use with the Delcath Hepatic Delivery System, and markets melphalan hydrochloride as a device under the trade name Delcath Hepatic CHEMOSAT Delivery System for Melphalan in Europe. Its primary focus is on the execution of its clinical development program in ocular melanoma liver metastases, intrahepatic cholangiocarcinoma, hepatocellular carcinoma, and certain other cancers that are metastatic to the liver. For more information, visit the company's website at www.delcath.com.

TheStreet (TST)

TheStreet (NASDAQ: TST) is a financial news and information provider to investors and institutions worldwide. The company's flagship brand, TheStreet (www.thestreet.com), is celebrating its 20th year of producing unbiased business news and market analysis for individual investors. The company's portfolio of institutional brands includes The Deal (www.thedeal.com), which provides actionable, intraday coverage of mergers, acquisitions and all other changes in corporate control; BoardEx (www.boardex.com), a relationship mapping service of corporate directors and officers; and RateWatch (www.rate-watch.com), which supplies rate and fee data from banks and credit unions across the U.S. For more information, visit the company's website at www.thestreet.com.

12:30 pm

GSI Technology (GSIT)

GSI Technology (NASDAQ: GSIT) is a fabless semiconductor company that designs, develops and markets memory products primarily for the networking and telecommunications markets. It offers synchronous static random access memory (SRAM) products, such as BurstRAMs for microprocessor cache applications; No Bus Turnaround SRAMs to address the needs of moderate performance networking applications; and SigmaQuad and SigmaDDR products that are double data rate and quad data rate synchronous SRAMs. For more information, visit the company's website at www.gsitechnology.com.

One Horizon Group (OHGI)

One Horizon Group (NASDAQ: OHGI) is an international company that develops and licenses software solutions to telecommunications operators. The company develops Horizon Platform, a bandwidth-efficient voice over Internet protocol platform for smartphones and tablets; and Horizon Call, a mobile application, which enables bandwidth-efficient VoIP calls over a smartphone using a 2G/EDGE, 3G, 4G/LTE, WiFi, or WiMax connection. It provides data applications, including multi-media messaging and mobile advertising under the Aishuo brand name; and software maintenance services. For more information, visit the company's website at www.onehorizongroup.com.

Atossa Genetics (ATOS)

Atossa Genetics (NASDAQ: ATOS) is a clinical-stage pharmaceutical company focusing on developing novel therapeutics and delivery methods to treat breast cancer and other breast conditions in the United States. The company is conducting a phase II clinical study using microcatheters to deliver fulvestrant as a potential treatment of ductal carcinoma in-situ and breast cancer; and a pharmaceutical program under development is Afimoxifene Topical Gel for the treatment and prevention of hyperplasia of the breast. For more information, visit the company's website at www.atossagenetics.com.

Optex Systems Holdings (OPXS)

Optex Systems Holdings (OTC: OPXS) manufactures and sells optical sighting systems and assemblies primarily for the U.S. Department of Defense, foreign military applications, and commercial markets. The company offers electronic sighting systems, mechanical sighting systems, laser and non-laser protected plastic and glass periscopes, howitzer sighting systems, thermal day/night periscopes, ship binoculars, replacement optics, and optical assemblies and laser filters. The company also provides various periscope configurations, rifle and surveillance sights, night vision optical assemblies, and precision optical assemblies utilizing thin film coating capabilities for optical systems and components primarily used for military purposes. For more information, visit the company's website at www.optexsys.com.

1:00 pm

Mobivity Holdings (MFON)

Mobivity Holdings (OTC: MFON) develops and operates proprietary platforms for brands and enterprises to conduct national and localized, data-driven mobile marketing campaigns in the United States. The company's platforms, which consist of software for phones, tablets PCs, and point of sale systems enable resellers, brands and enterprises to market their products and services to consumers through text messages sent directly to the consumers via mobile phones, mobile smartphone applications, and dynamically printed receipt content. For more information, visit the company's website at www.mobivity.com.

Propanc Health Group (PPCH)

Propanc Health Group (OTC: PPCH) is a development-stage healthcare company that focuses on the development of cancer treatments for patients with pancreatic and colorectal cancer. The company's lead product includes PRP, a patented formulation consisting of two pro-enzymes, such as trypsinogen and chymotrypsinogen, as well as the enzyme amylase designed to synergistically enhance anti-cancer effects. It is also developing a combination of anti-cancer agents working in combination with pro-enzymes, which enhance PRP's anti-cancer effect. For more information, visit the company's website at www.propanc.com.

Exactus (EXDI)

Exactus (OTC: EXDI) is a life science company that develops and commercializes Point-of-Care (POC) diagnostics for measuring proteolytic enzymes in the blood based on a proprietary detection platform. Through the use of its proprietary technology, the company anticipates that the use of the FibriLyzer could provide the basis for improved management of patients who are at-risk of hemorrhage, speeding treatment decisions and potentially improving patient outcomes and saving money. For more information, visit the company's website at www.exactusdx.com.

Function(x) (FNCX)

Function(x) (NASDAQ: FNCX) is a media company that operates Wetpaint.com, an online destination for entertainment news for millennial women covering the latest in television, music and pop culture. The company also offers daily fantasy sports experience both directly to consumers and to businesses desiring turnkey solutions. In addition, it operates Rant, a digital publisher that publishes original content in 13 different verticals, primarily sports, entertainment, pets, cars and food. For more information, visit the company's website at www.functionxinc.com.

1:30 pm

Tio Networks (TNCGF)

Tio Networks (OTC: TNCGF) is a cloud-based multi-channel bill payment processing and receivables management company serving the largest telecom, wireless, cable and utility bill issuers in North America. The company integrates with the back office billing systems to accept, validate and collect payments outside of the traditional bank channel, via self-service kiosk, retail walk-in, mobile and web solutions. Within its payment-processing network, Tio Networks has more than 65,000 endpoints enabling fast, convenient and secure access to expedited payment services. For more information, visit the company's website at www.tionetworks.com.

Arch Therapeutics (ARTH)

Arch Therapeutics (OTC: ARTH) is a biotechnology company developing an innovative, elegant and superior approach to the rapid cessation of bleeding (hemostasis) and control of fluid leakage (sealant) during surgery and trauma care. The underlying technology, exclusively licensed from a leading university, supports an innovative platform of smart materials that fulfill the criteria as a solution for a specialized field we call, "stasis and barrier applications." For more information, visit the company's website at www.archtherapeutics.com.

Kindred Biosciences (KIN)

Kindred Biosciences (NASDAQ: KIN) is a development-stage biopharmaceutical company that focuses on the development of therapies for pets. The company's strategy is to identify compounds and targets that have already demonstrated safety and efficacy in humans and to develop therapeutics based on these validated compounds and targets for dogs, cats and horses. Kindred Biosciences has a deep pipeline of novel drugs and biologics in development across many therapeutic classes. For more information, visit the company's website at www.kindredbio.com.

Inventergy Global (INVT)

Inventergy Global (NASDAQ: INVT) operates as an intellectual property (IP) investment and licensing company. It offers corporate licensing model for IP value creation that provides short-term returns and long-term licensing revenue. Inventergy acquires portfolios in the telecommunications industry primarily in core network infrastructure and mobile broadband communications segments. For more information, visit the company's website at www.inventergy.com.

Full House Resorts (FLL)

Full House Resorts (NASDAQ: FLL) owns, operates, develops, manages or invests in casinos and related hospitality and entertainment facilities. The company owns and operates the Silver Slipper Casino & Hotel in Hancock County, Mississippi, and the Rising Star Casino Resort located in Rising Sun, Indiana. In addition, the company owns and operates Stockman's Casino in Fallon, Nevada, the Grand Lodge Casino at the Hyatt Regency Lake Tahoe Resort, Spa & Casino in Incline Village, Nevada, on the north shore of Lake Tahoe. For more information, visit the company's website at www.fullhouseresorts.com.

2:00 pm

RCI Hospitality Holdings (RICK)

RCI Hospitality Holdings (NASDAQ: RICK) owns and operates upscale adult nightclubs serving primarily businessmen and professionals in the United States. The company operates in two segments: Nightclubs and Bombshells Restaurants and Bars. RCI Hospitality operates adult nightclubs under the brands: Rick's Cabaret, Tootsie's Cabaret, Club Onyx, XTC Cabaret, Cabaret East, Cabaret North, Silver City, Downtown Cabaret, Temptations, Jaguars, The Black Orchid, Seville, and Down in Texas Saloon. For more information, visit the company's website at www.rcihospitality.com.

Chanticleer Holdings (HOTR)

Chanticleer Holdings (NASDAQ: HOTR) owns, operates and franchises fast casual and full-service dining concepts in the United States and internationally. The company's portfolio of restaurants include establishments under the Hooters, American Burger Company, The Burger Joint, BT's Burger Joint, Little Big Burger, and Just Fresh names. For more information, visit the company's website at www.chanticleerholdings.com.

MabVax Therapeutics Holdings (MBVX)

MabVax Therapeutics Holdings (NASDAQ: MBVX) is a clinical-stage biopharmaceutical company engaged in the discovery, development and commercialization of proprietary human monoclonal antibody products and vaccines for the diagnosis and treatment of various cancers. MabVax Therapeutics has a pipeline of human monoclonal antibody products based on the protective immune responses generated by patients who have been immunized against targeted cancers. For more information, visit the company's website at www.mabvax.com.

CytoDyn (CYDY)

CytoDyn (OTC: CYDY) is a biotechnology company focused on the clinical development and commercialization of humanized monoclonal antibodies for the treatment and prevention of human immunodeficiency virus infection. The company's monoclonal antibodies under development for HIV infection are PRO 140, a therapeutic anti-viral agent, which is in phase III clinical trial for treating persons infected with HIV; CytoFeline, a phase II clinical trial anti-LFA-1 antibody for the treatment of feline immunodeficiency virus infection; and Cytolin, a preclinical trial product for the treatment of HIV infection. For more information, visit the company's website at www.cytodyn.com.

Youngevity International (YGYI)

Youngevity International (OTC: YGYI) develops and distributes health and nutrition related products and services primarily through independent direct selling network in the United States and internationally. Through its Direct Sales and Commercial Coffee segments, the company offers approximately 2,500 products, including nutritional products; sports and energy drinks; health and wellness-related services; lifestyle products such as spa, bath, garden and pet-related products; digital products; apparel and fashion accessories; and packaged foods. For more information, visit the company's website at www.ygyi.com.

2:30 pm

Second Sight Medical Products (EYES)

Second Sight Medical Products (NASDAQ: EYES) develops, manufactures and markets implantable prosthetic devices to restore functional vision to blind patients. The company's Argus II System is an implantable neurostimulation device that uses electrical stimulation of the retina to replace the function of the defunct photo-receptors in retinitis pigmentosa patients. The company sells its Argus II System to university hospitals, large medical centers, and distributors. For more information, visit the company's website at www.2-sight.com.

Terra Tech (TRTC)

Terra Tech (OTC: TRTC) engages in the design, marketing and sale of hydroponic equipment that leverages proprietary technology to create sustainable solutions for the cultivation of indoor agriculture in Newport Beach and Irvine, California. The company offers environmental controllers and timers, ballasts, bulbs, reflectors, nutrients, and portable hydroponic trailers, as well as the Big Bud and Little Bud, which are custom fabricated proprietary cultivation systems for horticulture enthusiasts, local urban farmers, and greenhouse growers. For more information, visit the company's website at www.terratechcorp.com.

RMG Networks Holding (RMGN)

RMG Networks Holding (NASDAQ: RMGN) provides enterprise-class digital signage solutions. Its suite of products includes proprietary software, software-embedded hardware, maintenance and support services, content and creative services, installation services, technical services, and third-party displays. The company offers Enterprise Software (ES), a robust software application server used to collect content from various applications and other data sources, as well as Media Players/Smart Digital Appliances, which are software pre-loaded media players that function as the content storage and rendering hardware between its ES content engine and the visual display end-points. For more information, visit the company's website at www.rmgnetworks.com.

Relmada Therapeutics (RLMD)

Relmada Therapeutics (OTCQB: RLMD) is a clinical-stage, biotechnology company developing adaptations of proven drug products with new chemical entities that potentially address areas of high unmet medical need in the treatment of central nervous system (CNS) diseases. The company has four products at various stages of development: d-Methadone (dextromethadone, REL-1017), LevoCap ER (REL-1015), oral buprenorphine (BuTab, REL-1028) and (MepiGel, REL-1021). The company's approach is expected to reduce clinical development risks and costs while potentially delivering valuable products to address areas of high unmet medical needs. For more information, visit the company's website at www.relmada.com.

Inuvo (INUV)

Inuvo (NYSE: INUV) is an Internet advertising technology and digital publishing company that operates through two segments: Partner Network, and Owned and Operated Network. The Partner Network segment provides ValidClick, a service platform designed to help the owners of websites and mobile applications to monetize their properties, as well as offers a pay-per-click solution where advertisements are targeted to consumers based on content and behaviors. The Owned and Operated Network segment builds and operates websites under the ALOT brand. It operates local.alot.com, health.alot.com, finance.alot.com, careers.alot.com, travel.alot.com, living.alot.com, education.alot.com, and search.alot.com. For more information, visit the company's website at www.inuvo.com.

3:00 pm

SharpSpring (SHSP)

SharpSpring (NASDAQ: SHSP) operates as a cloud-based marketing technology company worldwide. It offers SharpSpring, a marketing automation solution for small and medium-sized businesses. SharpSpring markets and sells its products and services through sales teams and third party resellers. The company was formerly known as SMTP, Inc. and changed its name to SharpSpring, Inc. in December, 2015. For more information, visit the company's website at www.sharpspring.com.

GrowGeneration (GRWG)

GrowGeneration (OTC: GRWG) operates through retail hydroponic and organic specialty gardening retail outlets. The company is engaged in the development of a branded e-commerce portal that stores and offers supplies to the hydroponic and gardening industry, including medium (farming soil), hydroponic equipment, lighting, plant nutrients and various additional products used by professional growers and specialty cultivation operations. For more information, visit the company's website at www.growgeneration.com.

Cesca Therapeutics (KOOL)

Cesca Therapeutics (NASDAQ: KOOL) focuses on the research, development and commercialization of autologous cell-based therapeutics for use in regenerative medicine. The company's automated blood and bone marrow processing systems enable the separation, processing, and preservation of cell and tissue therapy products. Its products include the SurgWerks system; the CellWerks system, a proprietary cell processing system with associated analytics for intra-laboratory preparation of adult stem cells from bone marrow or blood; and AutoXpress system, a proprietary automated device and companion sterile disposable for concentrating hematopoietic stem cells from cord blood. For more information, visit the company's website at www.cescatherapeutics.com.

First Harvest (HVST)

First Harvest (OTC: HVST) is a shell company that focuses on offering on-road tours. Its tourist destination features Mt. Charleston, Lake Mead National Recreation Area, Red Rock Canyon, Valley of Fire and the Grand Canyon. For riders looking for short overnights, First Harvest focuses on offering multiday trips to the Grand Canyon and roads of Southern California. The company also provides custom tours built from the ground up going to geological areas of the Southwest. For more information, visit the company's website at www.firstharvestcorp.com.

TrackX Holdings (TKXHF)

TrackX Holdings (OTC: TKXHF) is a cloud-based industrial, returnable and high-value asset tracking solutions provider. The company delivers a highly configurable software platform that offers visibility, utilization, analytics and executable business intelligence pertaining to high-value assets in a vast array of industries. TrackX's patented, enterprise-scalable asset tracking platform combines support for multiple auto-ID technologies with workflow, event management, alert notification and a comprehensive analytics platform to deliver significant value to a growing list of Fortune 500 customers. For more information, visit the company's website at www.trackx.com.

3:30 pm

Sevcon (SEV)

Sevcon (NASDAQ: SEV) designs and sells motor controllers, operating through its Electronic Controls and Capacitors segments. The Electronic Controls segment produces microprocessor based control systems for use in on and off-road vehicles, including cars, trucks, buses, motorcycles, fork lift trucks, aerial lifts, mining vehicles, airport tractors, sweepers and other electrically powered vehicles. The Capacitor segment produces and sells special metalized film capacitors to electronic equipment manufacturers for use as components in the power electronics, signaling and audio equipment markets. For more information, visit the company's website at www.sevcon.com.

Medovex (MDVX)

Medovex (NASDAQ: MDVX) focuses on developing medical devices primarily in the in the United States and Europe. Its current portfolio includes the DenerveX device for the treatment of conditions resulting from the degeneration of joints in the spine, as well as the IV suspension system that allows the transportation of IV poles secured to hospital beds, such as that one person could move a patient without separating the IV pole from the patient during transport. The company serves healthcare providers, physicians and third-party payors. For more information, visit the company's website at www.medovex.com.

Stellar Biotechnologies (SBOT)

Stellar Biotechnologies (NASDAQ: SBOT) is a biotechnology company that engages in the aquaculture, research and development, manufacture, and commercialization of keyhole limpet hemocyanin (KLH) protein primarily in Europe, the United States, and Asia. KLH is an immune-stimulating molecule used as an active pharmaceutical ingredient in various new immunotherapies, and as an injectable product to assess immune response. The company manufactures and supplies KLH protein under the Stellar KLH brand. Its products include Stellar KLH protein in various grades, formulations, and configurations for preclinical and clinical applications, as well as certain KLH-based in vitro diagnostic kits for preclinical use. For more information, visit the company's website at www.stellarbiotechnologies.com.

Reign Sapphire (RGNP)

Reign Sapphire (OTC: RGNP) is a fully reporting, DTC eligible company established as a "miners-gate to retail" model for fine sapphires -- rough sapphires to finished jewelry; a color gemstone brand; and a jewelry brand featuring Australian sapphires. The brand offers two distinct collections: Reign Red Carpet, which offers statement pieces at a higher end price point; and Reign Day to Night, which features subtle pieces that can go from day to evening at a more affordable price point. Reign Sapphires are guaranteed natural, guaranteed Australian, mined in an environmentally friendly manner, ethically processed with jewelry manufactured in the USA. For more information, visit the company's website at www.reignsc.com.

4:00 pm

Sunworks (SUNW)

Sunworks (NASDAQ: SUNW) provides photo voltaic based power systems for the residential, commercial and agricultural markets in the United States. It also designs, finances, integrates and manages systems ranging in size from 2 kilowatts for residential loads to multi megawatt systems for larger commercial projects. In addition, the company offers various installation services, including design, system engineering, procurement, permitting, construction, grid connection, warranty, system monitoring, and maintenance services to its solar energy customers. For more information, visit the company's website at www.sunworksusa.com.

Medite Cancer Diagnostics (MDIT)

Medite Cancer Diagnostics (OTC: MDIT) is a medical technology company that engages in the development, engineering, manufacture and marketing of medical devices and consumables for the detection, risk assessment, and diagnosis of cancer and related diseases. The company offers USE33, an ultrasonic decalcification instrument that automatically runs the process under controlled temperatures; TPC15 Duo or Trio; TES99; TES Valida; M530; A550; M380; TST44; COT20 linear staining systems; and RCM9000, ACS720, and TWISTER glass and robotic coverslippers. For more information, visit the company's website at www.medite-group.com.

OncoSec Medical (ONCS)

OncoSec Medical (NASDAQ: ONCS) is a biotechnology company that designs, develops and commercializes gene therapies, therapeutics and proprietary medical approaches to stimulate and guide an anti-tumor immune response for the treatment of cancer. Its lead product candidate is the ImmunoPulse IL-12, which is in phase II clinical trial for various indications, including metastatic melanoma and triple negative breast cancer. ImmunoPulse is an electroporation delivery device used in combination with the company's therapeutic product candidates, including DNA plasmids that encode for immunologically active agents, and to deliver the therapeutic directly into the tumor and promote an inflammatory response against the cancer. For more information, visit the company's website www.oncosec.com.

4:30 pm

Cytosorbents (CTSO)

Cytosorbents (NASDAQ: CTSO) is a critical care focused immunotherapy company that engages in the research, development and commercialization of medical devices with its platform blood purification technology incorporating a proprietary adsorbent polymer technology. Its principal product is CytoSorb device, an extracorporeal cytokine filter designed for the adjunctive therapy in the treatment of sepsis; for the adjunctive therapy in other critical care applications; the prevention of post-operative complications of cardiopulmonary bypass surgery and damage to organs donated by brain-dead donors prior to organ harvest; and the treatment of chronic kidney failure. For more information, visit the company's website at www.cytosorbents.com.

Pioneering Technology (PTEFF)

Pioneering Technology (PTEFF) engages in the development, manufacture and sale of cooking fire prevention solutions for residential and commercial markets. The company provides Safe-T-element, an electronically controlled solid cover plate installed on top of existing stovetop burners to prevent cooking fire; SmartBurner, an intelligent cooking system; Safe-T-sensor, a solution to prevent microwave fires and false alarms by interrupting power to the microwave at the first sign of smoke; and RangeMinder, a technology that prevents unattended cooking fires. For more information, visit the company's website at www.pioneeringtech.com.

Genius Brands International (GNUS)

Genius Brands International (OTC: GNUS) is a content and brand management company that provides content and products with a purpose for toddlers to tweens worldwide. The company offers children's entertainment content comprising the Baby Genius brand products that consist of songs, music videos, and toys, which feature classic nursery rhymes, learning songs, classical music, holiday favorites, and more for toddlers; and Warren Buffet's Secret Millionaire's Club, which offers animated series, classroom materials, an annual youth promotion, books, home video, and a line of consumer products. For more information, visit the company's website at www.gnusbrands.com.

Flux Power Holdings (FLUX)

Flux Power Holdings (OTC: FLUX) designs, develops and sells rechargeable lithium-ion batteries for industrial uses primarily in the United States. The company products include battery cell management system (BMS) that provides cell balancing, monitoring and error reporting functions for battery systems; battery modules, which are energy storage modules for industrial, governmental, and grid storage applications, as well as electrical vehicles; and air-cooled and liquid-cooled chargers to interface with its BMS. The company also integrates lithium packs in various applications, including industrial equipment and portable energy storage. For more information, visit the company's website at www.fluxpwr.com.

Xenetic Biosciences (XBIO)

Xenetic Biosciences (NASDAQ: XBIO) is a clinical-stage biopharmaceutical company that focuses on the discovery, development and planned commercialization of human drug therapies for the treatment of various conditions. Its drug delivery platform systems include PolyXen for creating next generation biologic drugs; OncoHist for the development of oncology drugs focused on orphan indications; Virexxa for the treatment of progesterone receptor negative endometrial cancer; and ImuXen for the development of vaccines that can simultaneously deliver multiple active pharmaceutical ingredients. For more information, visit the company's website at www.xeneticbio.com.

5:00 pm

TESSCO Technologies (TESS)

TESSCO Technologies (NASDAQ:TESS) is Your Total Source® for the product and value chain solutions that enable mobility and data wireless systems. Each quarter, the company serves more than 20,000 customers, including private system operators, state, local and federal government, resellers, and retailers. TESSCO supplies over 51,000 products from over 390 manufacturers and brands across base station infrastructure, network equipment, installation and test tools and mobile device accessories. The company supports a wide range of wireless and network connectivity solutions to support backhaul, remote monitoring and control, IoT and wireless device accessories. Under the Ventev brand TESSCO manufactures products for unmet needs in wireless in both the commercial and mobile device accessory markets. For more information, visit the company's website at www.tessco.com.

NTN Buzztime (NTN)

NTN Buzztime (NTN) provides interactive entertainment and dining technology to bars and restaurants in the United States and Canada. The company licenses its customizable solution that offers guests trivia, cards, sports and arcade games, and nationwide competitions, as well as self-service dining features, including menus, touchscreen ordering, and secure payment. NTN Buzztime also offers the Buzztime Entertainment On Demand (BEOND) platform and engages in leasing equipment, including tablets used in its BEOND tablet platform, and cases and charging trays for the tablets to network subscribers. For more information, visit the company's website www.buzztime.com.

Reed's (REED)

Reed's (NYSE: REED) makes sodas in the natural and specialty foods industry which are sold in over 15,000 natural and mainstream supermarkets nationwide. The company sells its products through an additional estimated 40,000 accounts that include specialty gourmet, natural food stores, retail stores, convenience stores and restaurants nationwide and in select international markets. Its seven award-winning non-alcoholic Ginger Brews are brewed rather than manufactured and use fresh ginger, spices and fruits in a brewing process that predates commercial soft drinks. The company owns the Virgil's Root Beer product line and the China Cola product line. In 2012, Reed's launched its Reed's Culture Club Kombucha line of organic live beverages. Other product lines include Reed's Ginger Candies and Reed's Ginger Ice Creams. For more information, visit the company's website at www.reedsinc.com.

Contact us: 212.418.1217